Skip to main content
SpringerLink
Log in

Clinically significant β-blocker drug interactions occur infrequently

  • Drug Reactions and Interactions
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Blaufarb I, Pfeifer TM, Frishman WH. β-Blocker: drug interactions of clinical significance. Drug Saf 1995 Dec; 13(6): 359–70

    Article  PubMed  CAS  Google Scholar 

  2. Beta-blocker drug interactions. In: Stockley IH. Drug interactions: a source book of adverse interaction, their mechanisms, clinical importance and management. 3rd ed. London: Blackwell Scientific, 1994: 407–34

  3. Martindale. The Extra Pharmacopoeia, 30th ed. London: Pharmaceutical Press, 1993: 624–1

    Google Scholar 

  4. British National Formulary No. 31. London: The Pharmaceutical Press, 1996 Mar: 73–9, 541

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clinically significant β-blocker drug interactions occur infrequently. Drugs Ther. Perspect 7, 13–16 (1996). https://doi.org/10.2165/00042310-199607110-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199607110-00005

Search

Navigation